Mayo Clinic - Q2 2024 holdings

$3.03 Million is the total value of Mayo Clinic's 4 reported holdings in Q2 2024. The portfolio turnover from Q1 2024 to Q2 2024 was 20.0% .

 Value Shares↓ Weighting
ACWI  MSCI ACWI ETF$1,951,152
+2.1%
17,3590.0%64.41%
+107.0%
ZNTL  Zentalis Pharmaceuticals Inc.$765,415
-74.0%
187,1430.0%25.27%
-47.4%
 UNITY BIOTECHNOLOGY INC$167,509
-17.7%
124,0810.0%5.53%
+67.0%
NMTC  Neuroone Medical Technologies$145,403
-33.3%
181,7540.0%4.80%
+35.2%
ISR ExitPerspective Therapeutics Inc.$0-724,641
-100.0%
-14.03%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2024-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Zentalis Pharmaceuticals Inc.12Q2 202448.0%
BLACK STONE MINERALS11Q3 202382.2%
Evelo Bioseciences Inc11Q3 20237.3%
BIOSIG TECH INC10Q2 20236.7%
Clearpoint Neuro Inc (Frmly MRI INTERVENTIONS INC)10Q3 20233.5%
UNITY BIOTECHNOLOGY INC8Q4 202223.1%
Neuroon Medical Technologies8Q2 20244.8%
MSCI ACWI ETF7Q2 202489.6%
EXACT SCIENCES CORP7Q2 20234.5%
UNITY BIOTECHNOLOGY INC6Q2 20245.5%

View Mayo Clinic's complete holdings history.

Latest significant ownerships (13-D/G)
Mayo Clinic Q2 2024 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VENTURE LENDING & LEASING IV INCMarch 16, 20056,0006.0%

View Mayo Clinic's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-09-03
13F-HR2024-08-12
13F-HR2024-05-13
13F-HR2024-02-13
13F-HR2023-11-14
13F-HR2023-08-09
13F-HR2023-05-05
13F-HR/A2023-02-09
13F-HR2023-01-26
13F-HR2021-08-12

View Mayo Clinic's complete filings history.

Compare quarters

Export Mayo Clinic's holdings